Brief: Grifols Receives FDA Approval For Its Malaria Blood Screening Assay
16/04/2026 13:23
April 16 (Reuters) - Grifols SA GRLS.MC: RECEIVES FDA APPROVAL FOR ITS MALARIA BLOOD SCREENING ASSAY Source text Further company coverage: GRLS.MC (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Grifols SA
See all newsSpanish stocks - Factors to watch on June 24
Brief: Grifols Approves Reduction Of Up To 10% Of Its Share Capital
Brief: Grifols Launches Fibrinogen Concentrate For Acute Bleeding Episodes In The U.S.
Brief: Grifols' Egypt Unit Adds €180 Mln Of Additional Investment In Project
Spanish stocks - Factors to watch on June 12